Skip to main content
. 2022 Aug 10;129(11):1929–1944. doi: 10.1017/S0007114522002616

Fig. 2.

Fig. 2.

Forest plots summarising the MD or SMD of post-trial fasting blood glucose (a), HbA1c (b), HOMA-IR (c) and serum insulin level (d) between Zn intervention and control arms for low risk-of-bias trials. MD, mean difference; SMD, standardised mean difference; HOMA-IR, homeostatic model assessment for insulin resistance.